NEW YORK (GenomeWeb News) – Biotest will distribute Biotecon Diagnostics' real-time PCR-based testing system for identifying microorganisms under a new, global sales agreement, Biotecon said today.
Beginning in September, Biotest's global microbiology business unit will sell Biotecon's Hygiene Screening System, which can identify Staphylococcus, Micrococcus, Kocuria, and Kytococcus in under two hours from a single bacterial colony, Biotecon said.
The company will market the system to customers in the pharmaceutical and environmental monitoring industries.
"Our customers in the pharmaceutical industry will benefit from this rapid microbiology method for the identification of bacterial colonies grown on our solid media, which are optimized for monitoring tests," Frank Schulze, executive VP of Biotest's global microbiology business unit, said in a statement.
Biotecon is based in Potsdam, Germany, and Biotest is based in Eppelheim, Germany.